Exelixis (EXEL) Shares Outstanding (Diluted) (2010 - 2026)
Exelixis (EXEL) recorded Shares Outstanding (Diluted) of 259.68 million in Q2 2027, down 8.7% from 284.39 million a year earlier and down 2.9% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2026, Exelixis reported Shares Outstanding (Diluted) of 281.86 million, down 4.8% from FY2025.
- Annual Shares Outstanding (Diluted) has a five-year compound annual growth rate of -2.6% (FY2021 to FY2026).
- Across earlier years, Shares Outstanding (Diluted) came in at 296.13 million in FY2025, 321.46 million in FY2023 (-1.0%) and 324.56 million in FY2022 (+0.7%).
- The Q2 2027 figure is the lowest quarterly Shares Outstanding (Diluted) in data going back to Q1 2020.
- On a year-over-year basis, Shares Outstanding (Diluted) has declined for six consecutive quarters, with an average decline of 5.7% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at 267.32 million (Q1 2027), 281.86 million (Q4 2026) and 278.54 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | 259.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 259.68 Mn |
| Apr 3, 2026 | 267.32 Mn |
| Jan 2, 2026 | 281.86 Mn |
| Oct 3, 2025 | 278.54 Mn |
| Jul 4, 2025 | 284.39 Mn |
| Apr 4, 2025 | 288.18 Mn |
| Jan 3, 2025 | 296.13 Mn |
| Sep 27, 2024 | 291.48 Mn |
| Jun 28, 2024 | 293.97 Mn |
| Mar 29, 2024 | 305.53 Mn |
| Dec 29, 2023 | 321.46 Mn |
| Sep 29, 2023 | 319.25 Mn |
| Jun 30, 2023 | 327.31 Mn |
| Mar 31, 2023 | 326.28 Mn |
| Dec 30, 2022 | 324.56 Mn |
| Sep 30, 2022 | 325.07 Mn |
| Jul 1, 2022 | 324.90 Mn |
| Apr 1, 2022 | 323.29 Mn |
| Dec 31, 2021 | 322.36 Mn |
| Oct 1, 2021 | 322.02 Mn |
API Access
Exelixis Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();